THEON
THEON Posts 35% Revenue Growth and Secures €325M Credit Facility
The Dutch-listed night vision maker reiterated H1 figures, guided to about €600m revenue for 2026 and lined up syndicated funding led by Alpha Bank.
REDFILED Newsdesk
News from SEC filings, FDA decisions and company releases, drafted with AI and checked by an editor before publication. How we work: redfiled.com/how-we-work/
POMRY
POMMERY Auditors Flag Material Going-Concern Doubt in 2025 Filing
The Champagne group's 2025 registration document carries an auditor paragraph on material uncertainty over its ability to continue as a going concern.
Other
MARTELA Calls EGM on Share Issue Worth 383% of Existing Shares
The Finnish furniture group wants shareholders to merge its two share classes and approve a directed issue of up to 17.8 million new shares.
Other
MARTELA Plans EUR 5–8M Directed Share Issue and Single Share Class
The Finnish office furniture maker wants to issue up to 17.8 million new shares, roughly 383% of its current share count, to shore up working capital.
PHVS
PHARVARIS Phase 3 Prophylaxis Trial Cuts HAE Attacks by 83%
Deucrictibant XR met the primary endpoint and all secondary endpoints in CHAPTER-3, clearing the way for filings starting in the first half of 2027.
XYZ
BLOCK Director Anthony Eisen Sells $1.46M in Class A Shares
Afterpay co-founder and Block director Anthony Eisen sold 18,000 Class A shares over three consecutive days in early September, filings show.
HTFL
HEARTFLOW CFO Verghese Sells $1.7M in Stock Over Two Days
Heartflow finance chief Vikram Verghese sold 33,416 shares on the open market on 2 and 3 September, leaving him with 221,143 shares.
WLDN
WILLDAN CEO Brisbin Exercises Options, Sells $5.2M in Stock
Willdan chief Thomas Brisbin exercised 58,757 options at $16.27 and sold the same number of shares at $88.14, leaving him with 96,687 shares.
FNKO
FUNKO CEO Josh Simon Sells $1.1M in Stock, Halving His Stake
Chief executive Josh Simon sold 181,893 Class A shares of Funko on 3 September, leaving him with 151,440 shares.
PAYD
PAID Discloses Forbearance on $5.97M of Defaulted Embolx Notes
Paid Inc filed a forbearance and loan modification agreement covering a $5,967,100 default balance owed by medical device firm Embolx, including $687,500 of fresh funding.
Regulatory
PHARMA EQUITY GROUP Faces Court Challenge to EUR 10.5M Arbitral Award
Interpatium has asked a Danish district court to set aside the June 2026 arbitration ruling that ordered it to pay Pharma Equity Group EUR 10.5 million.
NVO
NOVO NORDISK Semaglutide Trial in Children Aged 6 to 11 Hits Endpoint
In the STEP Young phase 3 trial, 40.4% of children treated with semaglutide were no longer classified as having obesity after 68 weeks, versus none on placebo.